Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000122

Director sold 1,674 shares at $20.39 ($34,133)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2024-05-15 Sale 10b5-1 −1,674 $20.39 $34,133 116,369 D: show line 1 in the form
Open-market sales · 1,674 sh · avg $20.39 · $34,133
Loading xslF345X05/wk-form4_1715977693.xml…